vimarsana.com

Page 19 - ஆராய்ச்சி சிறப்பானது கட்டமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Awakn Life Sciences Inc : Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the Ketamine in the Reduction of Alcoholic Relapse (KARE) Intervention Validated in a Phase II Clinical Trial

Awakn Life Sciences Inc : Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the Ketamine in the Reduction of Alcoholic Relapse (KARE) Intervention Validated in a Phase II Clinical Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Genetic study uncovers hidden pieces of?eye disease?puzzle?

Credit: Community Eye Health (Flickr) Scientists have taken a significant step forward in their search for the origin of a progressive eye condition which causes sight loss and can lead to corneal transplant. A new study into keratoconus by an international team of researchers, including a University of Leeds group led by Chris Inglehearn, Professor of Molecular Ophthalmology in the School of Medicine, has for the first time detected DNA variations which could provide clues as to how the disease develops. Keratoconus causes the cornea, which is?the clear outer layer?at the front of the eye, to thin and bulge outwards into a cone shape over time, resulting in blurred vision and sometimes blindness. It usually emerges in young adulthood, often with lifelong consequences, and affects 1 in 375 people on average, though in some populations this figure is much higher.

Pure Transplant Solutions and King s College London to Support Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

AUSTIN, Texas /Massachusetts Newswire – National News/ Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King’s College London, a leading university providing world-class teaching and cutting-edge research, to support the Phase IIa GAMECHANgER-1 clinical trial. The trial aims to determine whether adoptive transfer of regulatory T cells (Tregs) into HLA sensitised patients can suppress memory T and B cell responses against specific HLA antigens in order to extend the longevity of donor organs.

Scientists map the brain of a nematode worm

 E-Mail IMAGE: The spatial organisation of the C. elegans brain is modular. The image shows the different brain regions that process information to direct behaviours such as navigation, avoidance and feeding. The. view more  Credit: University of Leeds Researchers have mapped the physical organization of the brain of a microscopic soil-living nematode worm called Caenorhabditis elegans, creating a new model for the architecture of the animal s brain and how it processes information. In a surprise twist, they found a large degree of variation in the structure of some neural circuits or pathways in individual worms which complemented a core set of neural circuits common to different animals.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.